Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Management of hepatitis B: summary of a clinical research workshop.

Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS.

Hepatology. 2007 Apr;45(4):1056-75. Review.

PMID:
17393513
2.

Avoid the tragedy of hepatitis B reactivation in immunosuppressed patients.

Foont JA, Schiff ER.

Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):128-9. Epub 2007 Jan 30. No abstract available.

PMID:
17262070
3.

Chronic hepatitis B.

Lok AS, McMahon BJ.

Hepatology. 2007 Feb;45(2):507-39. No abstract available. Erratum in: Hepatology. 2007 Jun;45(6):1347.

PMID:
17256718
4.

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Kohrt HE, Ouyang DL, Keeffe EB.

Aliment Pharmacol Ther. 2006 Oct 1;24(7):1003-16. Review.

5.

Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.

Hwang LY, Kramer JR, Troisi C, Bull L, Grimes CZ, Lyerla R, Alter MJ.

Hepatology. 2006 Aug;44(2):341-51.

PMID:
16871571
6.

Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.

Mindikoglu AL, Regev A, Schiff ER.

Clin Gastroenterol Hepatol. 2006 Sep;4(9):1076-81. Epub 2006 Jul 24. Review.

PMID:
16861051
7.

Novel approaches to new therapies for hepatitis B virus infection.

Loomba R, Liang TJ.

Antivir Ther. 2006;11(1):1-15. Review.

PMID:
16518955
8.

Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.

Li YH, He YF, Jiang WQ, Wang FH, Lin XB, Zhang L, Xia ZJ, Sun XF, Huang HQ, Lin TY, He YJ, Guan ZZ.

Cancer. 2006 Mar 15;106(6):1320-5.

9.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Yeo W, Johnson PJ.

Hepatology. 2006 Feb;43(2):209-20. Review. No abstract available.

PMID:
16440366
10.

A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.

Jang JW, Choi JY, Bae SH, Yoon SK, Chang UI, Kim CW, Cho SH, Han JY, Lee YS.

Hepatology. 2006 Feb;43(2):233-40.

PMID:
16440357
11.

Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.

Yeo W, Hui EP, Chan AT, Ho WM, Lam KC, Chan PK, Mok TS, Lee JJ, Mo FK, Johnson PJ.

Am J Clin Oncol. 2005 Aug;28(4):379-84.

PMID:
16062080
12.

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

Hui CK, Cheung WW, Au WY, Lie AK, Zhang HY, Yueng YH, Wong BC, Leung N, Kwong YL, Liang R, Lau GK.

Gut. 2005 Nov;54(11):1597-603. Epub 2005 Jul 6.

13.

Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.

Yeo W, Ho WM, Hui P, Chan PK, Lam KC, Lee JJ, Johnson PJ.

Breast Cancer Res Treat. 2004 Dec;88(3):209-15.

PMID:
15609123
14.

Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.

Nagamatsu H, Itano S, Nagaoka S, Akiyoshi J, Matsugaki S, Kurogi J, Tajiri N, Yamasaki S, Koga H, Torimura T, Kumashiro R, Sata M.

Am J Gastroenterol. 2004 Dec;99(12):2369-75.

PMID:
15571585
15.
16.

[Lamivudine therapy for prevention of chemotherapy-induced reactivation of hepatitis B virus].

Jia J, Lin F.

Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):628-9. Chinese. No abstract available.

PMID:
15504300
17.

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.

Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM.

Gut. 2004 Sep;53(9):1363-5.

18.

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.

Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ.

Ann Hematol. 2004 May;83(5):270-5. Epub 2003 Dec 5.

PMID:
15060745
19.

Hepatitis B virus infection--natural history and clinical consequences.

Ganem D, Prince AM.

N Engl J Med. 2004 Mar 11;350(11):1118-29. Review. No abstract available. Erratum in: N Engl J Med. 2004 Sep 16;351(12):351.

PMID:
15014185
20.

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies.

Idilman R, Arat M, Soydan E, Törüner M, Soykan I, Akbulut H, Arslan O, Ozcan M, Türkyilmaz AR, Bozdayi M, Karayalçin S, Van Thiel DH, Ozden A, Beksaç M, Akan H.

J Viral Hepat. 2004 Mar;11(2):141-7.

PMID:
14996349
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk